Welcome to our professional cosmetics Repeat Insult Patch Test (RIPT/HRIPT) testing service page. At Protheragen, we understand the paramount importance of cosmetic safety, regulatory compliance, and brand integrity. Our comprehensive testing services assess potential cumulative irritation and allergic contact dermatitis, ensuring your cosmetic formulations are safe, globally compliant, and market-ready.
The HRIPT is a widely recognized method used to evaluate the potential adverse reactions of topical cosmetic products on the human skin. The protocol involves the repeated application of a product or its individual ingredients to the skin under occlusive or semi-occlusive patches over a specified time period.
For frequently used cosmetics, HRIPT is exceptionally valuable. Many chemical formulations do not trigger localized inflammation or irritation upon a single, isolated skin exposure. However, continuous and multiple exposures over time can induce strong cumulative irritation or delayed-type hypersensitivity. By identifying these underlying risks, HRIPT evaluates whether a cosmetic product may cause cumulative irritation or allergic contact dermatitis during typical consumer use.
Protheragen has a dedicated team of research professionals specializing in HRIPT studies. We offer a robust suite of solutions tailored to meet your unique product specifications and global marketing objectives.
We collaborate with your R&D teams to implement tailored research protocols that fit your product characteristics and regulatory requirements, ensuring all testing frameworks adhere to recognized international standards.
We carefully select and recruit suitable human volunteers from our extensive database, factoring in demographics such as age, gender, and skin type, as well as specific inclusion/exclusion safety criteria.
Test samples are applied to the participants' skin, and the patches are then sealed for the designated exposure durations. Subjects are continuously monitored by trained investigators for any physiological signs of irritation or sensitization.
We maintain strict data integrity throughout the testing, utilizing professional biostatistical software to accurately interpret participant responses and skin grading metrics.
Upon study completion, we deliver a comprehensive, audit-ready report summarizing the entire study design, methodology, individual panelist scores, and final dermatological interpretations.
A standard HRIPT consists of 3 distinct phases to thoroughly assess skin sensitization potential.
The test material is applied to the subject's skin under an occlusive patch 9 times (repeated regularly) over a 3-week period. This phase is designed to expose the immune system to potential allergens in the product matrix.
This is followed by a two-week rest period before the skin is exposed to the product again. During this timeframe, no patches are applied, allowing primary irritation to subside and immune memory to develop.
The product formulation is applied again to a naive skin site (a previously unexposed area). Reactions observed at the naive site during the challenge phase are evaluated to differentiate between irritant responses and true allergic sensitization. If necessary, a subsequent phase can be conducted to verify and better define the specific reaction.
Skin reactions are precisely graded according to a standardized scoring system, and all data points are interpreted by a certified Protheragen dermatologist or allergist.
Whether your regulatory strategy requires a preliminary safety study involving 50 subjects or a robust hypoallergenic substantiation involving 200 subjects, we are fully equipped to support your testing protocols.
In addition to HRIPT, Protheragen provides Primary Skin Irritation testing. The primary irritation study consists of a single 48-hour exposure patch test conducted with cohorts of 50, 100, or 200 subjects to establish baseline acute tolerance levels.
Protheragen strictly adheres to internationally recognized guidelines and industry standards to ensure all generated data are highly accurate, repeatable, and globally recognized by regulatory bodies.
1. What cosmetic claims can be substantiated via HRIPT?
Successful completion of an HRIPT study with an adequate sample size provides the rigorous scientific data needed to support prominent marketing claims such as "Hypoallergenic," "Dermatologist-Tested," "Proven Safe for Skin," or "Suitable for Sensitive Skin." These claims significantly enhance consumer trust and product marketability.
2. What is the standard timeline for a complete HRIPT study?
Because the testing protocol requires an induction phase (3 weeks), a mandatory rest period (2 weeks), and a challenge phase plus grading, the laboratory portion of a standard HRIPT takes approximately 6 to 8 weeks. Expedited timelines are available for urgent projects upon request.
3. What types of samples must be provided for HRIPT?
Clients need to provide finished cosmetic formulations or individual raw ingredients alongside safety documentation (such as raw material specifications). The exact sample volume depends on the number of subjects and the application dosage per patch. We will provide exact sample-quantity requirements during your initial project consultation.
4. How are skin responses graded during the testing?
Skin reactions are assessed by qualified investigators and dermatologists using a standardized visual scoring scale. Investigators evaluate localized physiological changes, focusing primarily on erythema (redness), edema (swelling), papules, or vesicles at designated intervals after patch removal.
To find out more about our testing capabilities or to discuss your specific testing requirements, please contact us. Our technical experts will evaluate your formulations and respond with a customized project outline within 2-4 working days.
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.
Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.
